fda semaglutide warning november 2025 Live Updates on Semaglutide's Current and Future Uses Comparative safety and side effects

2025;48(1 Suppl 1):S23951

Glucose-stimulated insulin secretion assay After intervention or transfection, glucose-stimulated insulin secretion (GSIS) assay was performed

Like all medications, side effects can occur and vary from patient to patient

US patent listings suggest generic semaglutide competition may remain limited into the early 2030s, depending on patent and exclusivity outcomes

Cross-sectional studies have shown that plasma and tissue glutathione concentrations decrease by approximately 10-15% per decade after age 45, and this decline is accelerated in conditions associated with chronic oxidative stress, including type 2 diabetes, cardiovascular disease, neurodegenerative diseases, HIV/AIDS, chronic liver disease, and chronic obstructive pulmonary disease (COPD) [2][3][10][11]

Juvederm, Sculptra): Add volume to cheeks, under eyes, and lips